Researchers at the University of California, Davis have demonstrated that THR-β agonists such as resmetirom, when repurposed, can effectively treat heart failure with preserved ejection fraction (HFpEF), addressing unmet clinical needs.

Researchers at the University of California, Davis have developed a scalable, plant-based method using somatic embryogenesis to produce high yields of water-soluble melanin externally from walnut tissues.

Together with Researchers at the University of Texas at Austin, researchers at the University of California, Davis have developed a method for synthesizing long polynucleotides using scaffolded cooperative binding and enzymatic ligation to improve yield, modification compatibility, and assembly accuracy.

Researchers at the University of California, Davis have developed a scalable and sustainable method using edible fungal pellets as microcarriers to grow animal cells for cultivated meat production.

Researchers at the University of California, Davis have developed a machine learning system that accurately detects and estimates retinal inflammation severity in uveitis patients using non-invasive OCT B-scan images.

Researchers at the University of California, Davis have developed a system and method for accurately extracting fetal photoplethysmography information from mixed maternal-fetal signals obtained non-invasively through the maternal abdomen.

Researchers at the University of California, Davis have developed technology that enables enhanced growth and colonization of beneficial gut bacteria through bacterial expression of heterologous alpha-fucosidases which target human milk oligosaccharides (HMOs), promoting a healthy gut microbiome.

Researchers at the University of California, Davis have developed alacto-oligosaccharide (GOS) formulations selectively promote growth of beneficial Bifidobacteria species by tailoring oligosaccharide chain lengths.